Combined effect of curcumin and 5-FU on apoptosis and COX-2 expression in human colon carcinoma cell line HT-29

Journal of China Pharmaceutical University

Volumn 37, Issue 6, 2006, Pages 555-558

  Jiang, Li Ping ^a   Du, Bo Yu ^b   Zhong, Lai Fu ^a  

^a China Japanese Joint Institute for Medical and Pharmaceutical Science   (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

5 fluorouracil; Apoptosis; Colon cancer; Combination effect; Curcumin

Indexed keywords

3(4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CURCUMIN; CYCLOOXYGENASE 2; FLUOROURACIL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN HT29; COLON CARCINOMA; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENTIATION; ENZYME INHIBITION; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IC 50; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; WESTERN BLOTTING;

EID: 33846070746     PISSN: 10005048     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. (Wang SR), (Chen BQ), (Wang CX), Chinese source. (Chin J Pub Heal), 1999,18(5):263-265.
2. (Jin L), (Zhang XZ), (Li MZ), Chinese source. (Shaanxi Med J),1999,28(11):700-702.
3. (Chen H), (Zhang ZS), (Zhang YL), Chinese source. (Chin J Gastroen Hepa),2000,9(2):107-109.
4. (Li HY), (Che Y), (Tang WX). Chinese source. (Chin J Hepa),2002,10(6):449-451.
5. Chen H, Zhong ZS, Zhong YL, et al. Curcumin inhibits cell proliferation by interfering with the cell cycle and inducing apoptosis in colon carcinoma cells [J]. Anticancer Res, 1999,19(5):3675-3680.
6. Cheng AL, Hsu CH, Lin JK, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions[J]. Anticancer Res,2001,21(4B):2895-2990.
7. Kelloff GJ, Crowell JA, Hawk ET, et al. Strategy and planning for chemopreventive drug development: clinical development plans II [J]. J Cell Bio Chem (Suppl), 1996,26:54-71.
8. Subongkot S, Frame D, Leslie W, et al. Selective cyclooxygenase-2 inhibition: a target in cancer prevention and treatment [J]. Pharmacotherapy,2003,23(1):9-28.
9. Goel A, Boland CR, Chauhan DP. Specific inhibition of cyclooxygenase-2 (COX-2) expression by dietary curcumin in HT-29 human colon cancer cells [J]. Cancer Lett, 2001,172(2):111-118.
10. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors[J]. Adv Enzyme Regul,1984,22:27-55.
11. Chou TC, Motzer R J, Tong Y, et al. Computerized quantitation of synergism and antagonism of taxol, topotecan and cisplatin against human teratocarcinoma cell growth: a rational approach to clinical protocol design [J]. J Natl Cancer Inst, 1994, 86(20):1517-1524.
12. (Du BY), (Jiang LP), (Zhong LF). Chinese source. (Chin J Pharmacol Taxicol),2005,19 (1):49-52.
13. Sun Y, Tang XM, Half E, et al. Cyclooxygenase-2 overexpression reduces apoptotie susceptibility by inhibiting the cytochrome c-dependent apoptotic pathway in human colon cancer cells[J]. Cancer Res,2002,62(21):6323-6328.